[Clinical analysis of 8 cases of refractory hematopoietic reconstitution after haploid hematopoietic stem cell transplantation treated with purified donor CD34-selected hematopoietic stem cells]

Zhonghua Xue Ye Xue Za Zhi. 2023 Dec 14;44(12):1027-1031. doi: 10.3760/cma.j.issn.0253-2727.2023.12.010.

[Article in Chinese]

Authors

Y He¹, R Ma¹, H F Wang¹, Y Y Zhang¹, M Lyu¹, X D Mo¹, C H Yan¹, Y Wang¹, X H Zhang¹, L P Xu¹, K Y Liu¹, X J Huang¹, Y Q Sun¹

Affiliation

¹ Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing 100044, China.

PMID: 38503527
PMCID: PMC10834869
DOI: 10.3760/cma.j.issn.0253-2727.2023.12.010

No abstract available

MeSH terms

Antigens, CD34 / analysis
Haploidy
Hematopoietic Stem Cell Transplantation*
Hematopoietic Stem Cells / chemistry
Humans

Substances

Antigens, CD34

Grants and funding

基金项目：国家自然科学基金（8227010768）；国家自然科学基金青年项目（81800116）；科技部重点研发计划（2021YFC2500300）